Vasopressin Administration During Laparoscopic Myomectomy: a Randomized Controlled Trial

PHASE4CompletedINTERVENTIONAL
Enrollment

152

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

April 30, 2015

Study Completion Date

June 30, 2015

Conditions
Blood Loss, Surgical
Interventions
DRUG

Vasopressin

Dilute vasopressin solution will be injected subserosally into myoma at time of minimally invasive myomectomy.

Trial Locations (1)

02115

Brigham&Women's hospital, Boston

All Listed Sponsors
collaborator

Beth Israel Deaconess Medical Center

OTHER

collaborator

North Shore Medical Center

OTHER

collaborator

Cedars-Sinai Medical Center

OTHER

lead

Brigham and Women's Hospital

OTHER

NCT01393704 - Vasopressin Administration During Laparoscopic Myomectomy: a Randomized Controlled Trial | Biotech Hunter | Biotech Hunter